Dr. Menacho is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
175 North Medical Drive East 5th floor
University of Utah Department of Neurosurgery
Salt Lake City, UT 84132Phone+1 801-581-6908Fax+1 801-581-4385
Summary
- Board certified neurosurgeon specializing in the care of patients with traumatic brain injuries as well as primary and metastatic brain tumors. Also board certified in surgical critical care and neurocritical care.
Education & Training
University of Texas M D Anderson Cancer CenterFellowship, Neurosurgical Oncology, 2015 - 2016
University of Utah HealthResidency, Neurological Surgery, 2008 - 2015- University of Utah HealthFellowship, Surgical Critical Care, 2011 - 2012
University of Vermont College of MedicineClass of 2008
Certifications & Licensure
MT State Medical License 2022 - 2026
UT State Medical License 2009 - 2026
ID State Medical License 2022 - 2025
NV State Medical License 2022 - 2025
TX State Medical License 2015 - 2025
WY State Medical License 2022 - 2025- American Board of Neurological Surgery Neurological Surgery
- American Board of Surgery Surgical Critical Care
Awards, Honors, & Recognition
- Teaching Faculty of the Year Department of Neurosurgery, 2020
Publications & Presentations
PubMed
- 10 citationsThe effect of supplementation of vitamin D in neurocritical care patients: RandomizEd Clinical TrIal oF hYpovitaminosis D (RECTIFY)Michael Karsy, Jian Guan, Ilyas M. Eli, Andrea A. Brock, Sarah T. Menacho
Journal of Neurosurgery. 2020-10-01 - 14 citationsCurrent practices and goals for mean arterial pressure and spinal cord perfusion pressure in acute traumatic spinal cord injury: Defining the gaps in knowledge.Sarah T. Menacho, Candace L. Floyd
The Journal of Spinal Cord Medicine. 2021-05-01 - 112 citationsImmune checkpoint blockade as a potential therapeutic target: surveying CNS malignancies.Sarah T. Garber, Yuuri Hashimoto, Shiao Pei Weathers, Joanne Xiu, Zoran Gatalica
Neuro-Oncology. 2016-10-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
